Dr. Olaf Stuve is a Professor in the Department of Neurology and Neurotherapeutics at UT Southwestern Medical Center, and Chief of Neurology at the VA North Texas Health Care System/ Dallas VA Medical Center.  At the Dallas VA Medical Center, Dr. Stuve attends to U.S. Veterans with neurological disorders. In addition to his clinical activities, he has been the Principal Investigator and site Principal Investigator for numerous clinical trials. Dr. Stuve also runs a research laboratory at UT Southwestern. His research interests include molecular and cellular markers of autoimmunity, immune tolerance, and experimental therapies for autoimmune disorders, and he has numerous ongoing collaborations with national and international investigators.

Dr. Stuve’s research has been supported by grants from the Department of Veterans Affairs, the National Multiple Sclerosis Society (NMSS), the Deutsche Forschungsgemeinschaft (DFG), Boehringer Ingelheim Fonds, and the Doris Duke Charitable Foundation. He has published over 200 research articles, review articles, editorials, and book chapters, and he has given over 200 invited presentations. Dr. Stuve is a fellow of the American Neurological Association (FANA), the American Academy of Neurology (FAAN), and the European Academy of Neurology (FEAN). He is an elected member of the Alpha Omega Alpha (AOA) Honor Medical Society. He has served on numerous editorial boards of medical and scientific journals, and has been a member of National Institutes of Health (NIH), and National Multiple Sclerosis Society (NMSS) study sections. Dr. Stuve is a past associate editor of JAMA Neurology, and a past steering committee member of the Immune Tolerance Network (ITN).

He received his medical degree from the Free University of Berlin, completed a medical doctoral thesis in physiology at the Max Delbruck Center for Molecular Medicine in Berlin magna cum laude, and earned a Ph.D. in immunology in the Department of Clinical and Experimental Immunology at Maastricht University. He completed a transitional internship at the University of Cape Town, and a preliminary internship and neurology residency at the University of Washington in Seattle. Dr. Stuve also received postdoctoral fellowship training in neuroimmunology at McGill University in Montreal, and at the University of California, San Francisco (UCSF).

Dr. Stuve has received numerous clinical teaching awards. He has mentored undergraduate students, graduate students, medical students, residents, post-doctoral fellows, and faculty. Dr. Stuve was elected Top Provider in Neurology at the VA North Texas Health Care System repeatedly by physician peers across medical and surgical specialties, and he has been listed in D Magazine's Best Doctors list.


Medical School
Freie University Berlin (1993), Medicine
Medical School
Max Delbruck Center for Molecu (1994), Physiology
Graduate School
Maastricht University (1994), Immunology

Research Interest

  • Experimental therapies for autoimmune disorders
  • Immune tolerance
  • Molecular and cellular markers of autoimmunity


Featured Publications LegendFeatured Publications

Human Aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with Neuromyelitis Optica.
Arellano B, Hussain R, Zacharias T, Yoon J, David C, Zein S, Steinman L, Forsthuber T, Greenberg BM, Lambracht-Washington D, Ritchie AM, Bennett JL, Stüve O Arch. Neurol. 2012 Sep 69 9 1125-31

Honors & Awards

  • Alpha Omega Alpha (ΑΩΑ) Honor Medical Society
    Honorary member, Texas Gamma Chapter (2013)
  • Clinical Teaching Award Neurology
    University of Texas Southwestern Medical School, Class of 2012 (2011)
  • Clinical Teaching Award Neurology
    University of Texas Southwestern Medical School, Class of 2011 (2010)
  • Clinical Scientist Development Award
    Doris Duke Charitable Foundation (2009)
  • Clinical Teaching Award Neurology
    University of Texas Southwestern Medical School, Class of 2008 (2007)
  • Postdoctoral scholarship
    Boehringer Ingelheim Fonds (2001)
  • Advanced postdoctoral fellowship grant
    National Multiple Sclerosis Society (NMSS) (2000)
  • H.-L. Teuber price
    The Montreal Neurological Institute, McGill University, Montreal (1996)
  • Postdoctoral fellowship grant
    Deutsche Forschungsgemeinschaft (DFG), Germany (1995)
  • Magna cum laude M.D. thesis
    Free University of Berlin, Germany (1994)